Top

Published in:

01-02-2018 | Clinical Study

Characteristics of cerebellar glioblastomas in adults

Authors: Thiébaud Picart, Marc Barritault, Julien Berthillier, David Meyronet, Alexandre Vasiljevic, Didier Frappaz, Jérôme Honnorat, Emmanuel Jouanneau, Delphine Poncet, François Ducray, Jacques Guyotat

Published in: Journal of Neuro-Oncology | Issue 3/2018

Abstract

Adult cerebellar glioblastomas (cGBM) are rare and their characteristics remain to be fully described. We analyzed the characteristics of 17 adult patients with cGBM and compared them to a series of 103 patients presenting a supra-tentorial glioblastoma (stGBM). The mean age at GBMc diagnosis was 53.4 years (range 28–77). A history of neurofibromatosis type I was noted in 3 patients. cGBM were hemispheric in 10 patients (58.8%), only vermian in 4 patients (23.5%), and both vermian and hemispheric in 3 patients (17.7%). A H3 K27M mutation was identified in 3/14 patients, a TERT promoter mutation in 3/14 patients and a methylated MGMT promoter in 3/14 patients. None of the patients (0/14) harbored an EGFR amplification, an IDH or a BRAF mutation. Association with neurofibromatosis type I and H3K27M mutations were mutually exclusive. Compared with stGBM, cGBM occurred in younger patients (53.4 vs. 63.2, p = 0.02), were more frequently associated with neurofibromatosis type I (18 vs. 1%, p = 0.009) and with a H3 K27M mutation (21 vs. 3%, p = 0.02). They also tended to have a more frequent multifocal presentation at diagnosis (21 vs. 4.3%, p = 0.06), more frequently resulted in leptomeningeal or intra-axial metastasis (44.5 vs. 5%, p = 0.002) and were associated with a shorter median overall survival (5.9 vs. 14.2 months, p = 0.004). The present study suggests that adult cGBM differ from their supra-tentorial counterpart and constitute a heterogeneous group of IDH wild-type gliomas with at least two subgroups, one associated with H3K27M mutations and the other with neurofibromatosis type I.

Chamberlain MC, Silver P, Levin VA (1990) Poorly differentiated gliomas of the cerebellum. A study of 18 patients. Cancer 65:337–340CrossRefPubMed

Bi WL, Chiocca EA (2013) Adult cerebellar glioblastomas: a distinct entity or parcel of the whole? World Neurosurg 80(6):181–183CrossRef

Mattos JP, Marenco HA, Campos JM et al (2006) Cerebellar glioblastoma multiforme in an dult. Arq Neuropsiquiatr 64(1):132–135CrossRefPubMed

Levine SA, McKeever PE, Greenberg HS (1987) Primary cerebellar glioblastoma multiforme. J Neuro-Oncology 5:231–236CrossRef

Adams H, Chaichana KL, Avendaño J et al (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80(6):237–243CrossRef

Akimoto J, Fukami S, Tsutsumi M et al (2009) Radiopathological characteristics of cerebellar malignant glioma in adults. Brain Tumor Pathol 26:59CrossRefPubMed

Babu R, Sharma R, Karikari IO et al (2013) Outcome and prognostic factors in adult cerebellar glioblastoma. J Clin Neurosci 20(8):1117–1121CrossRefPubMed

Gopalakrishnan CV, Dhakoji A, Nair S et al (2012) A retrospective study of primary cerebellar glioblastoma multiforme in adults. J Clin Neurosci 19(12):1684–1688CrossRefPubMed

Grahovac G, Tomac D, Lambasa S et al (2009) Cerebellar glioblastomas: pathophysiology, clinical presentation and management. Acta Neurochir 151(6):653–657CrossRefPubMed

10.

Gupta V, Goyal A, Sinha S et al (2003) Glioblastoma of the cerebellum. A report of 3 cases. J Neurosurg Sci 47(3):157–164PubMed

11.

Hur H, Jung S, Jung TY et al (2008) Cerebellar glioblastoma multiforme in an adult? J Korean Neurosurg 43:194–197CrossRef

12.

Jing X, Shen G, Su M et al (2015) Primary glioblastoma of the cerebellar vermis: a case report. Oncol Lett 10(1):402–404CrossRefPubMedPubMedCentral

13.

Lakičević G, Arnautović K, Mužević D et al (2014) Cerebellar glioblastoma multiforme presenting as hypertensive cerebellar hemorrhage: case report. J Neurol Surg Rep 75(1):e117–e121CrossRefPubMedPubMedCentral

14.

Linsenmann T, Monoranu CM, Vince GH et al (2014) Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report. BMC Res Notes 7:496CrossRefPubMedPubMedCentral

15.

Miller EM, Mani RL, Townsend JJ (1976) Cerebellar glioblastoma multiforme in an adult. Surg Neurol 5(6):341–343PubMed

16.

Mishra SS, Behera SK, Dhir MK et al (2014) Cerebellar giant cell glioblastoma multiforme in an adult. J Neurosci Rural Pract 5:295–297CrossRefPubMedPubMedCentral

17.

Saito T, Hama S, Kajiwara Y et al (2006) Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Anticancer Res 26:1351–1358PubMed

18.

Sciacero P, Girelli GF, Cante D et al (2014) Cerebellar glioblastoma multiforme in an adult woman. Tumori 100(3):74–78. https://doi.org/10.1700/1578.17236

19.

Stark AAM, Maslehaty H, Hugo HH et al (2010) Glioblastoma of the cerebellum and brainstem. J Clin Neurosci 17:1248–1251CrossRefPubMed

20.

Tamaki T, Eguchi T, Sakamoto M et al (2004) Glioblastoma multiforme of the cerebellum in an elderly man. J Chin Med Assoc 67(6):301–304PubMed

21.

Tsung AJ, Prabhu SS, Lei X et al (2011) Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution. J Neurooncol 105:555–562CrossRefPubMed

22.

Weber DC, Miller RC, Villà S et al (2006) Outcome and prognosis factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 1 66(1):179–186CrossRefPubMed

23.

Young I, Joung JH, Cheong KH, Bak et al (2006) Cerebellar glioblastoma presenting as a cerebellar hemorrhage in a child. J Korean Neurosurg Soc 39:374–377. https://doi.org/10.4103/0028-3886.73775

24.

Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed

25.

Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro-Oncology. 19:1127CrossRefPubMed

26.

Walter T, van Brakel B, Vercherat C et al (2015) O6-methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents. Br J Cancer 112(3):523–531CrossRefPubMedPubMedCentral

27.

Idbaih A, Criniere E, Marie Y et al (2008) Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro-Oncology 10(4):540–547CrossRefPubMedPubMedCentral

28.

Takahashi Y, Makino K, Nakamura H et al (2014) Clinical characteristics and pathogenesis of cerebellar glioblastoma. Mol Med Rep 10(5):2383–2388CrossRefPubMed

29.

Kuroiwa T, Numaguchi Y, Rothman MI et al (1995) Posterior fossa glioblastoma multiforme: MR findings. Am J Neuroradiol 16:583–589PubMed

30.

Utsuki S, Oka H, Miyajima Y et al (2012) Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 29(2):87–95CrossRefPubMed

31.

Kulkarni AV, Becker LE, Jay V et al (1999) Primary cerebellar glioblastomas multiforme in children. Report of four cases. J Neurosurg 90(3):546–550CrossRefPubMed

32.

Zito JL, Siva A, Smith TW et al (1983) Glioblastoma of the cerebellum. Computed tomographic and pathologic considerations. Surg Neurol 19(4):373–378CrossRefPubMed

33.

Pato-Pato A, Cimas-Hernando I, Lorenzo-González JR et al (2004) Cerebellar glioblastoma multiforme: a case report. Rev Neurol 38(9):839–842PubMed

34.

Lobão CAF, Barbosa AS, Nogueira J et al (2008) Cerebellar glioblastoma mutiforme in an adult. Arq Neuropsiquiatr 66(4):879–880CrossRefPubMed

35.

Singla N, Kapoor A, Savardekar A et al (2016) Malignant cerebellar peduncle lesions - rapid progression and poor outcome. Surg Neurol Int 7:S170–S173CrossRefPubMedPubMedCentral

36.

Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437CrossRefPubMed

37.

Kawarabuki K, Ohta T, Hashimoto N et al (2005) Cerebellar glioblastoma genetically defined as a secondary one. Clin Neuropathol 24(2):64–68PubMed

38.

Yang SY, Wang KC, Cho BK et al (2005) Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report. J Neurosurg 102(4 Suppl):417–422PubMed

39.

Ceccarelli M, Barthel FP, Malta TM et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164(3):550–563CrossRefPubMedPubMedCentral

40.

Nakata S, Nobusawa S, Yamazaki T et al (2017) Histone H3 K27M mutations in adult cerebellar high-grade gliomas. Brain Tumor Pathol. https://doi.org/10.1007/s10014-017-0288-6

41.

Gerrit H, Gielen M, Gessi J, Hammes et al (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytoma. Am J Clin Pathol 139(3):345–349CrossRef

42.

Aboian MS, Solomon DA, Felton E et al (2017) Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. Am J Neuroradiol 38(4):795–800CrossRefPubMedPubMedCentral

43.

Venneti S, Santi M, Felicella MM et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128(5):743–753CrossRefPubMedPubMedCentral

44.

Reyes-Botero G, Giry M, Mokhtari K et al (2014) Molecular analysis of diffuse intrinsic brainstem gliomas in adults. J Neurooncol 116(2):405–411CrossRefPubMed

45.

Nomura M, Mukasa A, Nagae G et al (2017) Distinct molecular profile of diffuse cerebellar gliomas. Acta Neuropathol 134:941–956CrossRefPubMedPubMedCentral

46.

Broekman ML, Risselada R, Engelen-Lee J et al (2009) Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I. Case Rep Med. https://doi.org/10.1155/2009/757898 PubMedPubMedCentral

47.

Guillamo JS, Créange A, Kalifa C et al (2003) Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126(Pt 1):152–160CrossRefPubMed

48.

Vizcaíno MA, Shah S, Eberhart CG et al (2015) Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol 46(9):1323–1330CrossRefPubMedPubMedCentral

49.

Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro-Oncology 16(1):140–146CrossRefPubMed

50.

Ameratunga M, McArthur G, Gan H et al (2016) Prolonged disease control with MEK inhibitor in neurofibromatosis type I-associated glioblastoma. J Clin Pharm Ther 41(3):357–359CrossRefPubMed

51.

Vanan MI, Underhill DA, Eisenstat DD (2017) Targeting epigenetic pathways in the treatment of pediatric Diffuse (high grade) gliomas. Neurotherapeutics 14(2):274–283CrossRefPubMed

Title: Characteristics of cerebellar glioblastomas in adults
Authors: Thiébaud Picart
Marc Barritault
Julien Berthillier
David Meyronet
Alexandre Vasiljevic
Didier Frappaz
Jérôme Honnorat
Emmanuel Jouanneau
Delphine Poncet
François Ducray
Jacques Guyotat
Publication date: 01-02-2018
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-017-2682-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Characteristics of cerebellar glioblastomas in adults

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients

Non-pharmacological interventions in patients with spinal cord compression: a systematic review

Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials

Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma

Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation

Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model